NGF and Parkinson disease: Of the few, are synthetic dimeric dipeptide mimetics (loop 4 of NGF) which augment neuronal survival in models of Alzheimer's disease, Parkinson's disease [15, 16], hemorrhagic stroke, and global cerebral ischemia [17, 18].